(Q36223870)

12 August 2017

1 reference

title

Coronary heart disease in HIV-infected patients (English)

1 reference

12 August 2017

1 reference

coronary artery disease

1 reference

Marshall J Glesby

1

1 reference

12 August 2017

1 June 2005

1 reference

12 August 2017

Current HIV/AIDS reports

1 reference

12 August 2017

2

1 reference

12 August 2017

2

1 reference

12 August 2017

68-73

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-005-0021-7

12 August 2017

0 references

cites work

Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0021-7

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0021-7

Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0021-7

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0021-7

Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0021-7

Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome

21 January 2018

1 reference

12 December 2020

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

1 reference

12 December 2020

Coronary heart disease in HIV-infected individuals

1 reference

12 December 2020

Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients

1 reference

12 December 2020

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

1 reference

12 December 2020

Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection

1 reference

12 December 2020

Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study

1 reference

12 December 2020

Acute myocardial infarction in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy

1 reference

12 December 2020

Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy

1 reference

12 December 2020

Vasodilator agents protect against indinavir nephrotoxicity

1 reference

12 December 2020

A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection

1 reference

12 December 2020

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin

1 reference

12 December 2020

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

1 reference

12 December 2020

Indinavir and systemic hypertension

1 reference

12 December 2020

Plasma hypercoagulability is correlated to plasma HIV load

1 reference

12 December 2020

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

1 reference

12 December 2020

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA.

1 reference

12 December 2020

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

1 reference

12 December 2020

Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients

1 reference

12 December 2020

Elevated blood pressure in subjects with lipodystrophy

1 reference

12 December 2020

Role of endothelial dysfunction in atherosclerosis

1 reference

12 December 2020

Case-control study of diabetes mellitus in HIV-infected patients

1 reference

12 December 2020

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

12 December 2020

Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy

1 reference

12 December 2020

Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance

1 reference

12 December 2020

Indinavir increases glucose production in healthy HIV-negative men.

1 reference

12 December 2020

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

1 reference

12 December 2020

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

12 December 2020

Effects of HIV protease inhibitor therapy on lipid metabolism

1 reference

12 December 2020

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

1 reference

12 December 2020

10.1007/S11904-005-0021-7

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16091251